Spectrum of common and uncommon compound epidermal growth factor receptor mutations in non-small cell lung carcinoma: An institutional experience from tertiary care centers from Eastern India
{{output}}
Background: Non-small cell lung cancer (NSCLC) constitutes about 85% of lung cancer cases. Epidermal growth factor receptor tyrosine kinase inhibitors ( EGFR -TKIs) have improved survival rates in patients with EGFR -sensitizing ... ...